Viking Therapeutics VKTX
NASDAQ VKTX
$36.75 -4.90 (-11.76%)
At close: Sep 24, 2026 · 4:00 PM EDT

Viking Therapeutics (VKTX) Enterprise Value (2015 - 2026)

Viking Therapeutics' (VKTX) quarterly Enterprise Value came in at $4.0 billion in Q2 2026, up 86.67% year-over-year from $2.2 billion in Q2 2025, and up 27.8% quarter-over-quarter from $3.2 billion in Q1 2026.

Analysis

Viking Therapeutics (VKTX) Enterprise Value (2015 - 2026) Analysis & Trends

Viking Therapeutics has disclosed Enterprise Value across 12 years of filings, most recently posting $4.0 billion for Q2 2026.

  • In Q2 2026, Enterprise Value rose 86.67% year-over-year to $4.0 billion; the TTM figure through Jun 2026 stood at $4.0 billion (up 86.67% YoY), while the FY2025 annual figure was $3.3 billion, down 7.09% from the prior year.
  • Enterprise Value came in at $4.0 billion for Q2 2026 at Viking Therapeutics, up from $3.2 billion in the prior quarter.
  • In the past five years, Enterprise Value ranged from a high of $8.1 billion in Q1 2024 to a low of -$118.9 million in Q1 2022.
  • Average Enterprise Value over 5 years is $2.5 billion, with a median of $2.0 billion recorded in 2025.
  • Year-over-year, Enterprise Value plunged 148.33% in 2022 and surged 1566.88% in 2023.
  • Over 5 years, Enterprise Value stood at $580.1 million in 2022, then soared by 158.74% to $1.5 billion in 2023, then soared by 138.98% to $3.6 billion in 2024, then fell by 7.09% to $3.3 billion in 2025, then increased by 21.49% to $4.0 billion in 2026.
  • Per Business Quant data, the three most recent Enterprise Value figures were $4.0 billion in Q2 2026, $3.2 billion in Q1 2026, and $3.3 billion in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 649.01 Bn 628.25 Bn 17.26 Bn
2 AbbVie 468.55 Bn 462.03 Bn 12.70 Bn
3 Merck 365.49 Bn 358.40 Bn 12.21 Bn
4 Novartis Ag 272.39 Bn 265.10 Bn 11.24 Bn
5 Astrazeneca 253.18 Bn 247.96 Bn 12.86 Bn
6 Amgen 219.53 Bn 205.54 Bn 7.24 Bn
7 Gilead Sciences 187.85 Bn 184.59 Bn 6.22 Bn
8 Pfizer 160.56 Bn 149.16 Bn 10.94 Bn
9 Vertex Pharmaceuticals 130.81 Bn 122.96 Bn 2.84 Bn
10 Viking Therapeutics 4.86 Bn 4.86 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 4.05 Bn
Mar 31, 2026 3.17 Bn
Dec 31, 2025 3.33 Bn
Sep 30, 2025 2.24 Bn
Jun 30, 2025 2.17 Bn
Mar 31, 2025 1.86 Bn
Dec 31, 2024 3.59 Bn
Sep 30, 2024 6.12 Bn
Jun 30, 2024 4.93 Bn
Mar 31, 2024 8.08 Bn
Dec 31, 2023 1.50 Bn
Sep 30, 2023 731.08 Mn
Jun 30, 2023 1.23 Bn
Mar 31, 2023 1.18 Bn
Dec 31, 2022 580.13 Mn
Sep 30, 2022 53.57 Mn
Jun 30, 2022 -83.75 Mn
Mar 31, 2022 -118.93 Mn
Dec 31, 2021 157.84 Mn
Sep 30, 2021 275.18 Mn
API Access

Viking Therapeutics Enterprise Value API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=enterprise-value&ticker=VKTX&period=max&api_key=YOUR_API_KEY